| HOME >> BIOLOGY >> TECHNOLOGY |
EXTON, Pa., Sept. 12 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) will present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum at The Ritz-Carlton San Francisco on Tuesday, September 25, 2007.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 7:55 a.m. (PT). The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 7:55 a.m. (PT) on Tuesday, September 25, 2007 and will remain on the website for approximately two weeks.
About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily in the endovascular, sports medicine and spine markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also commercialized a series of innovative products through its own direct endovascular sales force. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
Cautionary Note for Forward-Looking Statements. This press release
contains forward-looking statements that reflect the Company's current
expectations about its prospects and opportunities including the Company's
'/>"/>
| SOURCE Kensey Nash Corporation Copyright©2007 PR Newswire. All rights reserved |